Rentschler Biopharma SE
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO), focused exclusively on client projects.
Trending Articles
Related Content
Drug Delivery
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs), announced today that Gunnar Voss von Dahlen (54) has been appointed as Chief Financial Officer, effective December 1, 2023
Manufacturing
Rentschler Biopharma and Vetter unveil Xpert Alliance, a joint visualization of their successful strategic collaboration
The visualisation is designed to “bring to life” this ongoing
alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing
and expanding needs in the area of complex biopharmaceuticals